Efficacy of macrophage checkpoint Clever-1 inhibition with bexmarilimab plus azacitidine in myelodysplastic syndrome: Results from the ph1/2 BEXMAB study.

Authors: Naval Guastad Daver, Mika Kontro, Johanna Rimpiläinen, Marja Pyörälä, Timo Siitonen, Mikko Myllymäki, Joshua F. Zeidner, Ruth Witherall, Emma Searle, Petri Bono, Dr Birge Berns, Sofia Aakko, Maija Hollmen, Amer Methqal Zeidan, Anthony Selwyn Stein

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6513

Source: Full article

---

Abstract

6513